CD19 and B-cell acute lymphoblastic leukemia: Response and relapse outcomes in trials assessing CD19 CAR-T therapy with CD28/CD3ζ co-stimulatory domains in B-cell acute lymphoblastic leukemia with potential bridging to allogeneic hematopoietic cell transplantation.